Specifically, FASN has been identified as the crucial enzyme for lipogenesis, and its increased expression has been linked with an unfavorable prognosis in various cancer types (Kuhajda, 2006; Menendez and Lupu, 2007). The gene discussed is FASN; the disease is cancer.